PCORI Awards UNC Researcher $14.4 Million to Study Emerging Medications for PIBD Patients

The Patient-Centered Outcomes Research Institute (PCORI) announced the approval of funding totaling $14.4 million for UNC researcher to study new treatment options for pediatric inflammatory bowel diseases (PIBD). Michael D. Kappelman, MD, MPH, professor of pediatrics and epidemiology at the UNC School of Medicine, will serve as principal investigator.

Are GLP-1 drugs safe for children? Doctors say despite high use among youth, no unique health risks detected

With the skyrocketing popularity of weight-loss drugs like Ozempic, Wegovy, and Mounjaro, health experts are noticing an increasing trend of use among younger Americans.  According to new findings published in the Journal of the American Medical Association, the number of teens and young adults prescribed…

Scientists Discover New Clue Behind Age-Related Diseases and Food Spoilage

Berkeley Lab scientists have made a surprising discovery that could help explain our risk for developing chronic diseases or cancers as we get older, and how our food decomposes over time.